Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
ISFIYA, Israel and BOSTON, Jan. 30, 2017 /CNW/ -- Check-Cap Ltd. (NASDAQ: CHEK), engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening today announced that Bill Densel, CEO, will present live at VirtualInvestorConferences.com on February 2, 2017.
DATE: Thursday, February 2, 2017
TIME: 9:15 AM EST
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- In January 2017, Check-Cap announced it was enrolling the first patients in a clinical trial to support CE marking of its C-Scan® system for preparation-free colorectal cancer screening.
- During the third quarter of 2016, preliminary data demonstrating safety and clinical feasibility of the Company's capsule-based system for preparation-free examination of the colon were presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting and the United European Gastroenterology Week (UEGW).
- Check-Cap entered into a strategic relationship with GE Healthcare in to develop and validate high-volume manufacturing for X-ray source production and assembly into Company's capsule.
About Check-Cap Ltd.
Check-Cap is a clinical-stage medical diagnostics company developing the world's first ingestible capsule system for preparation-free, less-invasive colorectal cancer screening.
The capsule utilizes innovative ultra-low dose X-ray and wireless communication technologies to scan the inside of the colon as it moves naturally, while the patient follows his or her normal daily routine. After passage, the system generates a 3D map of the inner surface of the colon which enables detection of polyps and cancer. Designed to increase the willingness of individuals to participate in recommended colorectal cancer screening, the Check-Cap system addresses many frequently-cited barriers, including laxative bowel preparation, invasiveness, and sedation. The Check-Cap system is currently not cleared for marketing in any jurisdiction.
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
SOURCE Check-Cap Ltd.
To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/January2017/30/c8827.html
For further information: Check-Cap Ltd.: Investors: David Carey, Lazar Partners Ltd., 212-867-1768, [email protected]; Vivian Cervantes, PCG Advisory, 212-554-5482, [email protected]; Media: Erich Sandoval or Rob Sawyer, Lazar Partners Ltd., 213-908-6226 or 212-843-0209, [email protected], [email protected]; VirtualInvestorConferences.com: Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, [email protected]